Amneal Pharmaceuticals
AMRX
AMRX
153 hedge funds and large institutions have $316M invested in Amneal Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 48 increasing their positions, 51 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $417M → $316M (-$101M)
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
78% less call options, than puts
Call options by funds: $547K | Put options by funds: $2.49M
Holders
153
Holding in Top 10
1
Calls
$547K
Puts
$2.49M
Top Buyers
| 1 | +$2.46M | |
| 2 | +$1.48M | |
| 3 | +$1.19M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.18M |
| 5 |
HF
HRT Financial
New York
|
+$832K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$1.83M | |
| 3 | -$1.46M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$1.22M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$711K |